Smell and Taste Loss Recovery Time in COVID-19 Patients and Disease Severity
Open Access
- 2 March 2021
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (5), 966
- https://doi.org/10.3390/jcm10050966
Abstract
A significant proportion of people infected with SARS-CoV-2 report a new onset of smell or taste loss. The duration of the chemosensory impairment and predictive factors of recovery are still unclear. We aimed to investigate the prevalence, temporal course and recovery predictors in patients who suffered from varying disease severity. Consecutive adult patients diagnosed to be infected with SARS-CoV-2 via reverse-transcription–polymerase chain reaction (RT-PCR) at two coronavirus disease-2019 (COVID-19) Reference Hospitals were contacted to complete a survey reporting chemosensory loss, severity, timing and duration, nasal symptoms, smoking, allergic rhinitis, chronic rhinosinusitis, comorbidities and COVID-19 severity. In a cross-sectional study, we contacted 182 patients and 150 responded. Excluding the critically ill patients, 38% reported gustatory and 41% olfactory impairment (74% severe/anosmia). Most of the patients (88%) recovered their sense of smell by two months (median: 11.5 days; IQR: 13.3). For 23%, the olfactory loss lasted longer than a month. There were no significant differences in the prevalence and duration of chemosensory loss between groups of varying COVID-19 severity, and sexes (all p > 0.05). Moderate hyposmia resolved quicker than more severe loss (p = 0.04). Smell and taste loss are highly prevalent in COVID-19. Most patients recover fast, but nearly one out of ten have not recovered in two months.Keywords
This publication has 27 references indexed in Scilit:
- The role of self-reported smell and taste disorders in suspected COVID-19European Archives Of Oto-Rhino-Laryngology, 2020
- Relationship Between Odor Intensity Estimates and COVID-19 Prevalence Prediction in a Swedish PopulationChemical Senses, 2020
- Prevalence of Chemosensory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis Reveals Significant Ethnic DifferencesPublished by Cold Spring Harbor Laboratory ,2020
- Self‐reported olfactory loss associates with outpatient clinical course in COVID‐19International Forum of Allergy & Rhinology, 2020
- Olfactory Dysfunction and Sinonasal Symptomatology in COVID‐19: Prevalence, Severity, Timing, and Associated CharacteristicsOtolaryngology -- Head and Neck Surgery, 2020
- Olfactory Dysfunction: A Highly Prevalent Symptom of COVID‐19 With Public Health SignificanceOtolaryngology -- Head and Neck Surgery, 2020
- Smell dysfunction: a biomarker for COVID‐19International Forum of Allergy & Rhinology, 2020
- Time scale for resolution of olfactory dysfunction in COVID-19Rhinology journal, 2020
- The Eustachian tube: balloon dilatation and decongestants, and novel approaches in otolaryngology educationThe Journal of Laryngology & Otology, 2020
- Patient recall and recall bias of health state and health statusExpert Review of Pharmacoeconomics & Outcomes Research, 2004